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Abstract 
Cartilage tissue engineering is an emerging therapeutic strategy that aims to regenerate 
damaged cartilages caused by disease, trauma, ageing or developmental disorder. Since 
cartilage lacks regenerative capabilities, it is essential to develop approaches that deliver the 
appropriate cells, biomaterials, and signalling factors to the defect site. Materials and 
fabrication technologies are therefore critically important for cartilage tissue engineering in 
designing temporary, artificial extracellular matrices (scaffolds), which support three-
dimensional cartilage formation. Hence, this work aimed to investigate the use of Poly(3-
hydroxybutyrate), P(3HB)/microfibrillated bacterial cellulose (MFC) composites as 3D-
scaffolds for potential application in cartilage tissue engineering. The compression 
moulding/particulate leaching technique employed in the study resulted in good dispersion, 
and a strong adhesion between the MFC and P(3HB) matrix. Furthermore, the composite 
scaffold produced displayed better mechanical properties than the neat P(3HB) scaffold. 
Addition of 10, 20, 30, and 40 wt% MFC to the P(3HB) matrix, the compressive modulus was 
found to have increased by 35, 37, 64 and 124%, while the compression yield strength  
increased by 95, 97, 98 and 102% resepectively with respect to neat P(3HB). Both cell 
attachment and proliferation was found to be optimal on the polymer-based 3D composite 
scaffolds produced, indicating a non-toxic and highly compatible surface for the adhesion and 
proliferation of the mouse chondrogenic ATDC5 cells. The large pores sizes (60-83 µm) in the 
3D scaffold allowed infiltration and migration of ATDC5 cells deep into the porous network 
of the scaffold material. Overall this work confirmed the potential of P(3HB)/MFC composites 
as novel materials in cartilage tissue engineering. 
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1. Introduction 
Tissue engineering is a promising therapeutic strategy that has the potential to provide solutions 
for the repair or regeneration of diseased or damaged tissues. Tissue engineering was officially 
coined in 1988 at a National Science Foundation workshop, and defined by Langer and Vacanti 
to mean ‘the application of principles and methods of engineering and life sciences towards the 
fundamental understanding of structure-function relationships in normal and pathological 
mammalian tissues and the development of biological substitute to restore, maintain or improve 
tissue function1. The main challenge of tissue engineering is to mimic what happens in nature. 
Whilst, attempts are being made to engineer practically every tissue and organ in the body in 
vitro, work is also proceeding in creating tissue engineered organs such as liver, nerve, kidney, 
pancreas, heart muscle and valves, ligament, bones and cartilages. To date, the highest rates of 
success have been achieved in the areas of skin2, bladder3, airway4 and bone5,6 where tissue-
engineered constructs have been used successfully in patients. In addition, autologous 
chondrocyte implantation (ACI) and matrix-induced autologous chondrocyte implantation 
(MACI) are showing some success for cartilage repair. While major breakthroughs have taken 
place, significant research is required in a number of specific areas in the field7.  
The basic approach to tissue engineering involves the use of cells (isolated cells or cell 
substitute), three dimensional scaffolds and the delivery of signal factors such as growth and 
differential factors to targeted locations8. These approaches can be used alone or in 
combination to facilitate the repair, replacement or regeneration of damaged or degenerated 
tissues cause by disease, injuries or trauma. The use of isolated cells or tissue-inducing 
substances is considered when the defects are small and well contained. To engineer tissues of 
practical size scale and predetermined shapes, these two approaches are seriously limited. 
Hence, growing cells in three-dimensional scaffolds play a pivotal role. Scaffolds, therefore, 
plays a key role in guiding cells to grow, synthesize extracellular matrix and other biological 
molecules, and facilitate the formation of functional tissues and organs9.  
Generally, in designing Tissue engineering scaffolds, few basic requirements have been widely 
accepted10. First, a scaffold has to have interconnected pore structures, high porosity and proper 
pore size to allow for cellular penetration and diffusion of nutrients and waste products11. 
Second, a high surface area12-14 is needed to enhance high ligand density and promote cell 
adhesion, cell viability, migration, differentiation and extracellular matrix production. Third, 
biodegradability15 is highly desirable, and a proper degradation rate is needed to match the rate 
of neotissue formation. Fourth, the scaffold should be biocompatible16-19 to the cells and adhere 
and integrate with the surrounding native bone or cartilage. Fifth, the scaffold should be able 
to provide mechanical integrity16-18 depending on the defect location. The mechanical 
properties of the substrate to which the cells are attached are critical to the regulation of cellular 
mechanotransduction and subsequent cellular behavior. This has important implications for 
development, differentiation, disease, and regeneration. Albeit enormous success recorded in 
scaffold production, lack of vascularity in tissue engineered constructs has been a major 
challenge, and improving vascularisation strategies is considered one of the areas requiring the 
most extensive research in the field of tissue engineering20. Consequently, increasing research 
is being directed towards utilizing the mechanosensitive capacity of cells to develop tissue 
engineering scaffolds with specific mechanical properties that can be used to direct the 
behavior of the cells with which they interact21. The outcome of these researches is the 
development of a range of fabrication techniques aimed at producing scaffolds with adequate 
properties for tissue engineering. The techniques developed include; solvent casting22-25, phase 
inversion26,27, fiber bonding28-30, melt based technologies31-35, high pressure based methods36,37, 
freeze drying38,39, electrospinning40 and rapid prototyping technologies41-48.  
There are a series of problems associated with the use of scaffolds fabricated from a single 
phase biomaterial using the techniques enumerated above. For example, ceramic scaffolds, 
such as hydroxyapatite (HA), Bioglass and tri-calcium phosphate (TCP), are widely used for 
bone regeneration applications. Ceramic scaffolds (though, not generally used for soft tissue 
engineering) are typically characterized by high Young’s modulus, very low elasticity, and a 
hard brittle surface. From a bone perspective, they exhibit excellent biocompatibility due to 
their chemical and structural similarity to the mineral phase of native bone. Ceramics have been 
used extensively due to their osteoconductivity and osetoinductivity49,50. However, these 
materials have some major drawbacks owing to their brittleness which presents low mechanical 
stability and difficulty of shaping for implantation, thus, discouraging their use in the 
regeneration of large bone defects. Furthermore, due to factors that happen in vivo, such as 
osteoclastic activity, their degradation/dissolution rates are difficult to predict51.  
Different types of synthetic polymers have been used in the attempt to produce scaffolds 
including polystyrene, poly-l-lactic acid (PLLA), polyglycolic acid (PGA) and poly-dl-lactic-
co-glycolic acid (PLGA). Whilst these materials have proved to be successful as they can be 
fabricated with a tailored architecture, and their degradation characteristics can be controlled 
by varying the polymer matrix or the composition of the individual polymer52-54, they still have 
some drawbacks including the risk of rejection due to reduced bioactivity. In addition, there 
are concerns over the degradation process of PLLA and PGA as they degrade by hydrolysis, 
producing lactic acid/glycolic acid, thereby lowering the local pH which can lead to cell and 
tissue necrosis55.  
The third commonly used approach is the use of biological materials in Tissue Engineering 
scaffold fabrication. Biological materials including collagen, various proteoglycans, alginate-
based substrates and chitosan have all been used in the production of scaffolds for tissue 
engineering. Unlike synthetic polymer-based scaffolds, natural polymers are biologically 
active and typically promote excellent cell adhesion and growth. Furthermore, they are also 
biodegradable and so allow host cells, over time, to produce their own extracellular matrix and 
replace the degraded scaffold. However, fabricating scaffolds from biological materials with 
homogeneity and reproducible structures presents a challenge. In addition, the scaffolds 
generally have poor mechanical properties, which limit their use in, for example, load bearing 
orthopaedic applications. 
The problems described above, from the use of single phase substrates, have resulted in 
considerable research being devoted to the development of composite scaffolds comprising 
more than one phase. For example, a number of groups have attempted to introduce ceramics 
into polymer-based scaffolds56-59 while others have combined synthetic polymers with natural 
polymers60 in order to enhance their biological activity. Whilst, the resultant composite 
scaffolds have shown some promises, each consists of at least one phase which is not found 
naturally in the body and they all have associated problems with biocompatibility, 
biodegradability or both. A more typical approach is the use of natural polymer-based 
composite scaffolds to enhance biological and/or mechanical properties.  
Among the available bio-based fillers, bio-based bacterial cellulose are considered a very 
attractive material because of their good mechanical properties (high aspect ratio, high tensile 
strength, Young’s Modulus), high purity, crystallinity, high degree of polymerization, 
abundant from renewable resources, high liquid loading capacity, biodegradability, 
biocompatibility (induce negligible foreign body and inflammatory responses), non-toxicity, 
and sustainability61-66. The biocompatibility of BC-based products have made them suitable for 
several biomedical applications, including membranes for wound dressings67, scaffolds for 
tissue engineering68-72, substrates for cell seeding73, structures for biomineralization of 
hydroxyapatite74. It has been proven that BC nanofibres can mimic collagen nanofibres for Ca-
P minerals deposition through biomineralization. The resultant Ca-P minerals are platelet-like 
calcium-deficient hydroxyapatite (Hap), similar to the hydroxyapatite found in natural bone75.  
The objectives of this work therefore, were to investigate the use of a natural polymer-based 
(microfibrillated cellulose, MFC and P(3HB) 3D composite scaffold for articular cartilage 
repair. To our knowledge, this is the first report of the use a bio-based polymeric composite 
scaffold for potential use in articular cartilage repair. 
Cartilage is a flexible connective tissue found in many areas of the human body, including the 
joints, ribs, nose, ear, trachea and intervertebral discs. In these regions cartilage can act as 
structural support, maintain shape or absorb shock during physical exercise. Cartilage defects 
resulting from aging, joint injury, and developmental disorders can cause unbearable joint 
pains, and in some cases result in loss of mobility. Furthermore, considering the current high 
aging population and the growing problem of obesity, there has been increasing number of 
osteoarthritis patients’ cases. Besides, with a more active adult population, cartilage damage 
resulting from sports injuries can often result in premature cartilage degeneration, thus, 
necessitating the need for proactive research in the treatment and engineering of injured and 
damaged cartilage tissues. Unlike most other connective tissues, cartilage is predominantly 
avascular leading to hypoxic environments that limit the rate of cellular growth and tissue 
regeneration76, 77. This in turn limits the capacity of cartilage to repair itself in the event of 
damage. Due to its limited ability to self repair, cartilage therefore is an ideal candidate for 
tissue engineering. 
 
2. Experimental Procedures 
2.1. Bacterial strain, cells and culture medium 
Poly(3-hydroxybutyrate) was produced following previously developed biotechnological 
methods.78 The bacterial cellulose was produced by A. xylinus (JCM10150), obtained from the 
Culture Collection of University of Westminster, London, UK and grown in YGC medium 
containing in (gL-1): Yeast extract, 5.0; calcium carbonate, 12.0; glucose, 50.0) and maintained 
at 30 ◦C, pH 5.0 for 5 days. 
The proliferation assays were performed using Murine ATDC5 cell line. ATDC5 is an 
excellent in vitro model cell line for skeletal development. The cell line was grown in 
chondrogenic media containing; low glucose Dulbecco's Modified Eagle Medium (DMEM), 
supplemented with 10% fetal  calf  serum, 1% (w/v) penicillin and 1% (w/v) 
streptomycin solution, 5 ng mL-1 transformed growth factor Beta-3 (TGF β-3), 50 µg mL-1 
ascorbate-2-phosphate, 1µM dexamethasone, 0.1 mM (100x) nonessential amino acids,  and 5 µg 
mL-1 Insulin. The media for the cell lines were changed every two days and maintained at 37 °C, 
5% CO2 and passaged on confluence by adding 2 mL of trypsin and incubate for 5 mins. 
2.2. Production of micro-fibrillated bacterial cellulose 
Batch cultures of Acetobacter xylinum (JCM10150) were grown in flasks at 27°C under static 
condition and were harvested after five days of incubation. The cellulose pellicles formed were 
harvested, boiled in a 2% (w/v) NaOH solution and washed several times with de-ionised water 
to remove the sodium hydroxide. The gel-like pellicles produced were first blended with a 
blender (Osterizer blender, Pulse matic, UK) to break down the pellicles to smaller pieces and 
later homogenised using a homogenizer (Bucks Laboratory Mixer Emulsifier, UK) to produce 
microfibrillated bacterial cellulose (MFC). 
The MFC produced were later chemically modified to produce relatively hydrophobic MFC by 
treating water excluded MFC with a solution containing a mixture of acetic acid, toluene and 
perchloric acid in a ratio of (200:250:1) mL, respectively in a stoppered flat bottom flask. The 
suspension of MFC in the mixture above was homogenised for 2 min before the addition of 
desired amount of acetic anhydride and stirred at room temperature for 72 h. At the end of the 
reaction, the suspension was centrifuged at 4600 rpm (12,000g) for 30 min and subsequently 
washed three times with a toluene/ethanol/acetone mixture (4:1:1 by volume) to remove 
unreacted compounds and by-products formed during the acetylation reaction.  
 
2.3. Composite scaffold production 
P(3HB) and P(3HB)/MFC composite Scaffolds were prepared using the novel compression 
moulding/particulate leaching technique developed and by employing sucrose grains as the 
porogen for porosity. The porogen was prepared by placing small quantity of sucrose grains 
atop a mesh with 100 µm openings. The mesh was shaken to allow sucrose grains with sizes 
smaller than 100 µm to pass through the mesh. The process was repeated with 80 µm opening 
mesh, however, with the sucrose that passed through the 100 µm openings. The sucrose grains 
retained by the 80 µm opening mesh (80-100µm in size) were later collected and used for the 
study. The mould for the scaffold fabrication was prepared by cutting open the other end of a 
5 mL disposable syringe to form a cylinder. 
For P(3HB) scaffold preparation, 1.0 g of P(3HB) was dissolved in 10 mL of chloroform 
and 20 g of sucrose grains, prepared above, was added. The resulting mixture was stirred 
to obtain a homogenous paste. The semi-solid paste formed was placed into a prepared 
cylinder above. With the help of a plunge, the semi-solid paste was moulded into shape 
by applying pressure up to 10 bars in the cylinder. The moulded cylindrical solids were 
air dried at 30oC. 
For P(3HB)/MFC scaffold preparation 1.0 g of P(3HB) was dissolved in 10 mL of 
chloroform and appropriate amounts of modified MFC were separately dissolved in 
chloroform and homogenised. Each of the appropriate amounts of homogenised MFC 
was later mixed with P(3HB) solution and sonicated for 1 min (Ultrasonic Homogenizers 
US200, Philip Harris Scientific, UK) to improve the dispersion of the modified MFC in 
the P(3HB) solution. 20 g of sucrose grains (prepared above) was later added to the 
P(3HB) solution and stirred to form a semi-solid paste. The semi-solid paste formed was later 
moulded into shape as described above. The moulded cylindrical solids were air dried at 30°C 
for 6 h and later immersed in 500 mL of deionised water (which was occasionally changed) for 
12 h to allow complete dissolution of sugar grains from the solid cylindrical body. After about 
12 h the porous scaffolds were removed from the water and air dried at 30 °C. The porous 
scaffolds were sectioned using sharp blades to cut scaffolds in the size of 0.5 x 0.5 x 0.5 cm3 for 
further experiments including characterisation and bioactivity. 
 
2.4. Scaffold characterisation 
Scanning electron microscopy (SEM): Scanning electron microscopy (SEM) was used to examine 
the microstructure of the 3D scaffolds samples. Samples were sectioned using a sharp blade and 
placed on a freshly cleaved 8 mm diameter aluminium stubs and gold plated for 2 min. Images were 
taken at various magnifications and acceleration voltages (max. of 20 kV) to avoid beam damage to 
the polymer. For each image at least 20 pore throats were measured, taking the longer diameter in the 
cases where the throat appeared elliptical because of perspective.  
 
Mechanical test: The compressive strength of P(3HB) and P(3HB)/MFC composite scaffolds 
was measured using a Perkin-Elmer Dynamic Mechanical Analyser (DMA 7e, Perkin-Elmer 
Instruments, USA) at room temperature as described elsewhere.79 Cylindrical samples of 2 mm 
diameter and around 2 mm height were cut with surgical scalpels, and then compressed. The 
initial load was set at 1 mN and it was increased to 6000 mN at a rate of 200 mN min-1. Four 
repeat specimens were tested for each sample during this analysis and the results presented in 
this work are average of four measurements. Elastic modulus of the scaffold was determined 
using a stress strain representation. Methodology for curve interpretation and modulus 
calculation was taken from ASTM D1621-04a standard ‘Compressive properties of rigid 
cellular plastics’.  
 
Porosity measurements on the scaffolds: The gravimetric method was employed in measuring 
the porosity of the fabricated scaffolds. The samples were weighed dry, and then filled with 
distilled water under vacuum, and subsequently weighed again. Porosity was calculated as the 
quotient of the volume of pores (see below) and the total volume of the scaffold. 
The volume of pores, Vpore, was deduced from the weight difference between dry (mdry) and 
wet (mwet) sample, according to equation below assuming that the amount of water absorbed 
by the scaffold composite phase is negligible due to its high hydrophobicity.80 Thus, the volume 
of pores equals the volume occupied by the absorbed water. 
 
   , where, dwater is the density of water. 
 
The volume of P(3HB) and P(3HB)/MFC was calculated from the dry weight of the scaffold 
assuming a density of P(3HB) about 1.25 gcm-3, which corresponds to the average crystallinity 
measured by DSC. Density was calculated on the basis of amorphous phase and crystalline 
phase densities of 1.18 and 1.26 gcm-3, respectively.81 For each sample type, at least five 
measurements were carried out and the obtained values were averaged. 
 
2.5. Protein Adsorption 
The protein adsorbed by the neat P(3HB) and P(3HB)/MFC composite samples was quantified 
by a Micro-BCA assay using the supplier instructions (Perce, USA). The protein adsorbed on 
each of the samples was extracted by an immersion in 500 µl of 10% SDS and incubated for 
24 h at room temperature. 
After 24 h, the protein adsorption capacity of the neat P(3HB) and composite scaffold samples 
were evaluated. Materials were incubated with complete culture medium for 30 min. After the 
immersion, proteins were desorbed with a 10% SDS solution and loaded on 10% SDS-page 
electrophoresis gels. Gels were scanned with a denitometric ‘OneDscan apparatus’ (Scan 
Metrix, France). Protein concentration was obtained by comparison with BSA standards. 
 
2.6 Change in pH of the immersed SBF of the neat P(3HB) and P(3HB)/MFC 3D composite 
For in vitro change in pH assessment, a total of nine samples from each group were immersed 
in SBF for 1, 2, 3 and 4 weeks and 20 mL PBS was used for each sample. The pH-values of 
SBF were monitored every week by an electrolyte-type pH meter (PHS-2C, Jingke Leici Co., 
Shanghai, China). Three samples from each group were removed from the SBF at the 
predetermined time point (1, 2, 3 and 4 weeks) and the pH of the SBF was measured with the 
pH probe. The average values for the pH readings were recorded.  
 
2.7 In vitro proliferation assays 
A cell seeding density of 100 000 cells cm-2 was used for the scaffolds. The samples were 
placed in a polystyrene 24 well flat bottomed tissue culture plate (TPP, Switzerland), with the 
scaffold samples placed in the centre of the well and 30 µL of the cell suspended media was added 
for attachment of the ATDC5 cells. The plates were incubated in a humidified environment 
(37°C, 5% CO2) for 3 h to enable the cells to attach to the test material. After 3 h, 1 mL of 
chondrogenic media was added to each of the wells containing cell seeded scaffolds and the plates 
were replaced in the humidified incubator and maintained at 37oC, 5% CO2. Neat P(3HB) scaffold 
was used as the control. The media in the wells were changed every 2 days. The cellular growth at 
24, 96 and 168 h (1, 4 and 7 days) of incubation was evaluated by Alamar Blue assay (AbD 
Serotec, UK). Alamar Blue was added to the samples (10% v/v of the medium) and incubated at 
37oC in an incubator (with 5% CO2) for 4 h. Aliquots of 200 µL from each sample well were 
transferred to a black 96-well plate and the fluorescence of Alamar blue was measured using a 
fluorescence plate reader (Fuoroskan, Lab Systems) at an excitation wavelength of 530 nm (A530) 
and an emission wavelength of 590 nm (A590). The experiment was performed in triplicates while 
readings were taken in duplicates.  
 
2.8 Total protein production analysis 
For the measurement of total protein produced by the mouse chondrogenic ATDC5 cell lines, 
osteogenic media was prepared by addition of dexamethasone solution to a final concentration of 
0.1 µM and Ascorbic acid 2-phosphate solution to a final concentration of 0.2 mM to a low glucose 
Dulbecco's Modified Eagle Medium (DMEM), supplemented with 10% fetal  calf  
serum, 1% (w/v) penicillin and 1% (w/v) streptomycin solution. The ATDC5 cells were seeded 
to the scaffolds and grown using freshly prepared osteogenic medium. Aliquots of supernatants were 
taken at day 1, 7, 14 and 21 days for the quantification of total protein produced by the cells using 
Qubit™ Protein Assay Kits and by following the protocols in the manufacturers’ manual.  
The Qubit® 2.0 Fluorometer gives values for the Qubit™ protein assay in µg/mL. This value 
corresponds to the concentration after sample was diluted into the assay tube. To calculate the 
concentration of sample, the following equation was used: 
  
 
Where, QF value = the value given by the Qubit® 2.0 Fluorometer, X = the number of 
microliters of sample added to the assay tube. 
 
 
3.0 Results 
P(3HB), produced from Bacillus cereus SPV and chemically modified MFC were combined to 
form P(3HB)/MFC composite 3D scaffolds, using a novel compression moulding/particulate 
leaching technique developed in this work. Sucrose grains of sizes 80-100 µm were used as 
porogen materials. The 3D composite scaffold were characterised thoroughly. Detailed results 
of the production and characterisation of the materials are given below. 
 
3.1. Preparation of P(3HB)/MFC composite scaffold 
P(3HB)/MFC composite scaffolds were prepared using a novel compression 
moulding/particulate leaching technique. This novel technique was developed in this study 
using an inexpensive technique which can be carried out at room temperature. The dimension 
of the scaffolds produced using this technique is alterable as shown in Fig. 1(A) and (B). Also, 
the porosity of the scaffolds can be controlled by adjusting the size and amount of the porogen 
material (sucrose grain). The mechanical strength of the scaffold can be altered and controlled 
by adjusting the amount of P(3HB) and filler employed in the composite production. Also, the 
shape of the pores in the scaffold can be varied and this is dependent on the shape of the porogen 
material employed during scaffold fabrication.  
 
 
Figure 1: Digital images of different dimensions and type of scaffolds that were 
produced using the compression moulding/particulate leaching technique.  
  
3.2. Microstructural characterisation of P(3HB)/MFC Composite 3D Scaffolds 
A selection of SEM micrographs of the fractured surface of composite materials with 40% of 
MFC produced using the novel compression moulding/particulate leaching technique is shown 
in Fig. 2. Two different magniﬁcations were used in order to display both the MFC dispersion 
within the P(3HB) matrix and the interfacial adhesion between the two composite components. 
The SEM image of the surface of the scaffold highlights the interconnected pore network in 
the scaffold microstructure, Fig. 2(a) and (b). This is necessary for the infiltration of cells 
during cartilage regeneration. Fig. 2(c) displayed the SEM image of the morphology of pores 
in the scaffold highlighting the microtopography of the surface of the pore throat (inside pore).  
  
Figure 2 (a) Digital imge of the P(3HB)/MFC scaffold after particulate leaching; (b) 
SEM image of P(3HB)/MFC composite scaffold at lower magnification showing the 
microstructural pores in P(3HB)/MFC scaffold; (c) SEM image of P(3HB)/MFC 
composite scaffold at higher magnification displaying the irregular pore structure with 
high interconnectivity. 
 
3.3. Compression tesing:  
The effect of MFC content on the large strain behavior of MFC/P(3HB) composites was 
investigated up to their failure. Figure 3 shows a typical stress-strain curve of neat 
P(3HB) and P(3HB)/MFC composite of various MFC content (10, 20, 30, 40, and 50 
wt%) tested in air. The curves demonstrated the typical behaviour of a scaffold 
undergoing deformation and comprise three distinct regions: a linear-elastic region 
followed by a plateau of roughly constant stress leading into a final region of steeply 
rising stress. The linear-elastic region represents the period of loading of the 3D scaffold 
with strain. At this stage, the 3D scaffold can still withstand the strain applied to it 
without much deformation. As the strain increases, the 3D scaffolds reached the offset 
yield strength and maintain a steady stress represented by the plateau in Figure 3. 
Further increase in the strain led to the crushing of the 3D scaffold which resulted in a 
densification process in the 3D scaffold. This phenomenon caused the stress level to 
rise quickly resulting in a steeply rising stress profile. 
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 Figure 3. Typical stress-strain curves of neat P(3HB) and P(3HB)/MFC scaffolds of 
various MFC content under compression loading. (A) Normal curve (B) Enlarged curve 
for lower strain values. The experiment was performed in triplicates. For the purpose of 
clarity, only the profiles for single analysis have been shown. 
 
Fig. 4 shows the compressive modulus and compressive yield strength of the neat P(3HB) and 
P(3HB)/MFC composite scaffold with varying wt% of MFC content. It can be deduced from 
Figure 4 that the incorporation of MFC  into the polymer matrix significantly influenced the 
compressive modulus of the composites. Whilst, the compressive modulus of the neat P(3HB) 
was found to be 0.08 ± 0.01 MPa, the compressive modulus on addition of  10, 20, 30, and 40 
wt% MFC were found to have increased by 35, 37, 64 and 124% respectively. From the 
statistical analysis performed on the result, statistical difference (p<0.05) was found between 
the compression modulus of the neat P(3HB) and the P(3HB)/MFC composites, and among the 
composites. However, compressive modulus of the P(3HB)/MFC composite was found to 
decrease to 0.16 ± 0.02 MPa on increasing the MFC content further to 50 wt%. On the other 
hand, the compressive yield strength of the composite was found to increase progressively with 
the incorporation of MFC to the polymer matrix. Whilst, the compressive yield strength 
measured on the neat P(3HB) scaffold was 0.58 ± 0.06 KPa, this was found to have improved 
to 95, 97, 98, 102 and 109 % with respect to the neat P(3HB) scaffold, on addition of 10, 20, 
30, 40 and 50 wt% MFC respectively. Besides, a statistical difference (p<0.05) was calculated 
between the compressive yield strength of the neat P(3HB) scaffold and the P(3HB)/MFC 
composite scaffolds. However, no significant difference (p>0.05) was found in the yield 
strength among the composites containing different amounts of MFC. 
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Figure 4. Compressive modulus and yield strength for P(3HB)/MFC scaffolds with 
various MFC (wt%) content measured in air (n=4, error = ±SD). 
 
3.4 Protein adsorption assay on P(3HB)/MFC composite 3D scaffold 
Protein adsoprtion  was measured on both the neat P(3HB) and P(3HB)/MFC 3D scaffold to 
understand the effect of addition of MFC to the P(3HB) matrix on this parameter. This was 
necessary in order to gain more understanding of the role of the added MFC in protein 
adsorption by the composite scaffolds. The potential of a biomaterial to function as a scaffold 
in tissue regeneration is partly based on their role in enhancing cell attachment, differentiation 
and subsequent tissue formation, which in turn is governed by their capacity for protein 
adsoprtion . The result of the protein adsorption test shown in Figure 5 showed that the addition 
of MFC to the polymer matrix improved protein adsoprtion by the composite material by 8, 
15, 20, 22, 27% by the addition of 10, 20, 30, 40 and 50 wt% MFC repectively when compared 
to 490 µg/cm2 protein absorped by the neat P(3HB) scaffold. Hence, the protein adsorbed by 
the composite material increased progressively as the amount of MFC added to the polymer 
matrix increased. 
 
 
Figure 5: Total protein adsorption study on P(3HB)/MFC composite scaffold using 
foetal bovine serum (n = 3; error bars = ± SD). 
 
3.5 Change in pH of the immersed SBF of the neat P(3HB) and P(3HB)/MFC 3D composite 
scaffolds: It has been suggested that acidic degradation products of polymers such as PLA 
(polylactic acid) and P(3HB) result in a decrease in pH around the surrounding environment of 
degrading polymeric materials.55 However, the degradation product of P(3HB) is much less 
acidic than that of PLA. Whilst, very low pH is not desirable during degradation of medical 
polymeric materials, very high pH is equally not desirable as this could affect the physiological 
functions of the surrounding cells and tissues. Hence, the change in the pH of the immersed 
SBF for the neat and composite P(3HB) materials was monitored over a period of time. The 
details of the variation in the pH of the SBF medium are shown in Fig. 6. No rapid change in 
pH of the SBF in the presence of neat P(3HB) and the P(3HB)/MFC composite was observed 
throughout the incubation period. However, it was found that the pH of the SBF for the 
composite samples increased slightly from the initial 7.35 to 7.47 after 7 days of immersion in 
SBF. The pH was found to remain constant until after 14 days and later gradually decreased to 
6.4 after 30 days of incubation. For the neat P(3HB), the pH was found to increase slightly 
from the initial 7.35 to 7.45 at 12 days and gradually decrease to a pH of 5.8. Comparison of 
decrease in pH revealed that the pH decrease in the SBP with neat P(3HB) decreased a lot more 
than that observed in the composite. Hence, the composite maintained a near neutral pH which 
is an advantage for its use as a tissue engineering material.  
  
 
Figure 6. Change in pH of the SBF solution in which the neat P(3HB) (●) and P(3HB)/MFC 
(▲) 3D scaffold were incubated. 
 
3.6. Cell Proliferation analysis on P(3HB)/MFC composite material 
The Murine ATDC5 cell line has been well characterised and validated. It is widely used as an 
in vitro model of chondrogenesis. 82 Based on this fact, the cell line was chosen to gain more 
understanding on the biocompatibility of the P(3HB)/MFC composite in the context of this 
cartilaginous cell line. Cell proliferation study of ATDC5 cell lines was measured using the 
Alamar blue assay. Fig. 7 shows the trend of growth pattern of the ATDC5 cell lines on the 
neat P(3HB) composite scaffold.  No significant differences (p>0.05) were found between cell 
proliferations on the samples analysed at day 1. However, on day 4 and 7, slight differences in 
cell proliferation were noticed on the tested samples. P(3HB)/MFC 3D composite scaffold with 
40 wt% MFC content showed a slightly lower cell proliferation at day 4 (97%) when compared 
to the neat P(3HB) scaffold samples (108%) but on day 7, it was found that the cell proliferation 
on the 40 wt% MFC content composite was higher (117%) than that observed on the neat 
P(3HB) scaffold (105%)  
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Figure 7: Cell proliferation relative to the control (neat P(3HB)) set at 100% for 1, 4 
and 7 days growth, using Alamar Blue assay on P(3HB)/MFC composite 3D Scaffold 
with different amount of MFC content. Data (n=3, error bars =±SD, p<0.01, *) were 
compared using ANNOVA. 
 
3.7. Cell Morphology  
A detailed morphological study on cell adhesion and proliferation on the P(3HB)/MFC 
3D composite scaffold was further performed on the composite scaffold containing 40 
wt% MFC. Figure 8.0 shows the morphology of the ATDC5 cells on TCP and 2D 
P(3HB)/MFC constructs on Day 1 and 7, as a control for comparison with the 
morphology observed on the 3D scaffolds described in this work.  
 
 
 
 Figure 8.0: SEM images of ATDC cells growing at day 1 on (A1) Tissue culture plastic,  
(B1) neat 2D P(3HB) film and (C1) neat P(3HB)/MFC composite films; on day 7 on (A2) 
Tissue culture plastic, (B2) Neat P(3HB) and (C2) P(3HB)/MFC composite films shown at 
(x 500) magnifications. 
 
The morphology of the ATDC5 cells grown on the P(3HB)/MFC composite scaffold 
on Day 1, 4 and 7 were examined by SEM and typical images are shown in Figs. 8.1, 
8.2 and 8.3. No difference was seen in morphology of cells examined with SEM in both 
the neat P(3HB) and composite containing 40wt% MFC. However, slightly fewer cells 
were found in the pores of the neat P(3HB) 3D scaffold on day 7 (data not shown). 
However, cells grown on 40wt% MFC composite showed long filopodia unlike those 
grown on the neat P(3HB) scaffold. The morphology of the composite scaffold surface 
proved to provide favourable conditions for the attachment of cells. This is evident from 
the cell adhesion, cell division, formation of long filopodia and proliferation observed 
on Day 1 as seen in Fig. 8.1b, c & e. On Day 4, the cells were found to have a more 
flattened and stretched morphology, overlaying on each other and occupying and taking 
up the shape of the pore throat (inside the wall of pore opening) (Fig. 8.2b, e & f).  By 
day 7, the cells were found to have grown, bridging the pores in the scaffold and further 
overlaying on each other (Fig. 8.3). In general, the chondrocytes grew well and 
exhibited good attachment and morphological features such as long filopodia on the 
composite scaffolds on Days 1, 4 and 7. 
 
 
Figure 8.1 SEM micrographs of ATDC5 cells grown on P(3HB)/MFC composite scaffolds on 
Day 1; (a) ATDC5 cells growing on the pores in the scaffold; (b) ATDC5 cells still in round 
shape adhering to the microtopography of the walls of the pores in the scaffold;  (c) Cells 
growing filopodia after division and moving away for flattening; (d) Group of cells growing in 
the pore of the scaffold material (e) and (f) show a  higher magnification of (d) (indicated by 
the blue line for a clearer view). 
 
 
Figure 8.2: SEM micrographs of ATDC5 cells growing within the pores in the P(3HB)/MFC 
3D composite scaffold at Day 4. (a) well spread ATDC5 cells extending their filopodia (b) A 
higher magnification of (a) Flattening and layering of ATDC5 cells on the polymeric 
composite 3D substrate; (c) highlights the densely growing ATDC5 cells inside the pore (d) 
A higher magnification of (c) (indicated by the blue line) The cells began rounding up for 
division and proliferation. 
 
 
 
 
 
 
 
Figure 8.3: SEM micrographs of ATDC5 cells growing in the P(3HB)/MFC 3D composite 
scaffold at Day 7. The yellow arrows in (a) indicate the folding and withdrawal of filopodia, 
possibly for division and the red arrow highlights cells growing and bridging the pores. (b) 
Well flattened cells on the polymeric 3D composite substrate, while the blue arrows in Figure 
(c) highlight rounded ATDC5 cells ready for division.  
 
Whole Protein Production by Murine ATDC5 cell line grown on 3D P(3HB)/MFC composite: 
To further understand the capability of the composite material to support the growth of Murine 
ATDC5 cell line, in order to assess future cartilage formation, whole protein production was 
investigated. The hypothesis behind this investigation was that since cell activities including 
cartilage formation, can be correlated with the extracellular whole protein production, increase 
or decrease in the whole protein released into the surrounding medium is an indication of the 
ability of the test material to hinder or promote cartilage formation. Statistical analysis 
performed shows no significant difference (p>0.01) among the test materials (neat P(3HB) and 
P(3HB)/MFC) at various time points investigated. 
 
 
4. Discussion  
The use of biomaterial implantation to surpass the limitations of conventional treatments is one 
of the main objectives of tissue engineering. Tissue engineering has the potential to produce a 
supply of immunologically tolerant tissue substitutes that can grow with a patient and lead to 
a permanent solution to a damaged organ or tissue without the need for supplementary 
therapies. Hence, to repair damaged organ or tissue, relevant cell(s) are required to be grown 
in vitro into a structure mimicking the three-dimensional structure of the damaged organ or 
tissue. But, cells lack the ability to grow in favoured 3D orientations and thus define the 
anatomical shape of the tissue. Instead, they randomly migrate to form a two-dimensional layer 
of cells. Thus, porous 3D scaffolds are required for cell(s) seeding and subsequent cell 
attachment and colonisation.83Architectural design of tissue engineering scaffolds into porous 
structures, thus, plays a very important role in permitting cell adhesion, proliferation and 
characterisation and finally, defines the ultimate shape of the new tissue.  
Both the neat P(3HB) and composite porous scaffolds produced using the novel compression 
moulding/particulate leaching were in general very homogenous, since the formation of 
agglomerates was not observed. The absence of agglomeration confirmed that the acetylation 
of the easily accessible surface hydroxyl groups (OH) made the MFC more compatible with 
the non polar solvent used and the P(3HB) matrices. This ensured the formation of a well 
dispersed homogenous mixture of P(3HB) and MFC for composite production. The more 
important aspect of the novel technique used in the production of the scaffolds is that the 
technique is very simple, inexpensive and less time consuming unlike solvent 
casting/particulate leaching or electrospinning. Furthermore, the porous microstructure 
produced using this technique is comparable and in many cases better in the physico-
mechanical properties (compressive modulus of 0.19 MPa and yield strength of approximately 
1.20 KPa with the addition of 40 wt% of MFC) than the ones achieved for other PHA scaffolds 
reported so far in literature like P(3HB-co-3HV)/BG scaffold prepared using compression 
moulding, thermal processing, and salt particulate leaching technique.84 
The SEM micrographs provide evidence of the strong interfacial adhesion between the 
cellulose ﬁbres and the P(3HB) matrix, as shown by excellent cellulose ﬁbre dispersion within 
the P(3HB) matrix, without noticeable aggregates. It was indeed observed that the 
characteristic nano- and micro-ﬁbril network of MFC was maintained and totally impregnated 
within P(3HB) matrix. These results clearly corroborated the superior mechanical properties of 
the MFC-based composites compared with those of the neat P(3HB) counterparts, as suggested 
by the mechanical tests discussed below. Surface topography is very important for the adhesion 
of mammalian cells on biomaterials and this was observed on the throats of the pores in the 
scaffold. The surface microtopography can be attributed mainly to the homogenous dispersion 
of the MFC filler. The surface structures of the sucrose grains which formed the pores would 
have also contributed to the microtopography. The interconnected pore network in the scaffold 
was as a result of the amount of sucrose grains added and the homogenous mixture of the 
composite and the sucrose grains during scaffold fabrication. 
Generally, incorporation of additives into a polymer matrix is an effective way of improving 
the physico-mechanical properties of biomaterial for specific tissue engineering applications. 
Large increments in the mechanical performance of several composite materials have 
previously been reported by the incorporation of modest proportions of bacterial cellulose 
nano-ﬁbres in other kinds of matrices.85 Li et al., observed the improvement of the compressive 
yield of P(3HB-co-3HV) by 156% of the initial strength of the polymer on addition of 20 wt% 
of Bioglass®.86 Hence, the superior mechanical properties of MFC/P(3HB) composites 
compared with the neat P(3HB) scaffold, conﬁrmed the good interfacial adhesion and the 
strong interactions between the MFC and the P(3HB) matrix. These results can be explained 
by the inherent morphology of bacterial cellulose with its nano- and micro-ﬁbrillar network. 
The reinforcing effect might result from the effect of formation of a stiff hydrogen bonded 
cellulose network.87 This behaviour was attributed to an improved dispersion and / or 
compatibility between the bulk P(3HB) and the modified MFC. Thus, increasing the amount 
of MFC in the P(3HB) matrix increased the compressive modulus and compressive yield 
strength of the composites. The increased compressive modulus is an excellent property that 
will allow the use of this composite in load bearing applications where the neat polymer will 
fail due to poor mechanical properties. Surprisingly, the composite with 50 wt% MFC did not 
show the highest compressive modulus, indicating that there is a limit to the amount of MFC 
that can be added to the polymer matrix to improve the compressive yield strength.  
Investigations on the total protein production showed none of the tested material hindered total 
protein production. However, Hardingham et al. have observed that chondrocytes grown on 
bacteria cellulose monolayer became fibroblastic and lose their characteristic pattern of matrix 
protein production.88 In this work, the P(3HB)/MFC composite material was able to support 
growth of chondrocytes and did not induce the cells to differentiate into fibroblasts. This is due 
to the nano- and micro-structural surfaces provided by a combination of both MFC fibres and 
P(3HB) matrix which fundamentally enhanced protein–surface interactions, thus, making the 
composite material, a good material for cartilage tissue engineering. 
Gopferich has observed that pH is an important factor that influences the rate of hydrolysis 
during degradation in polymers.89 The pH of SBF in which both types of samples were 
immersed increased a little above the initial pH of the buffer (7.35). Since the degradation 
product of P(3HB) is a 3-hydroxy butyric acid and the pKa of 3-hydroxybutyric acid is 4.70, 
so at pH 7.35, the 3-hydroxybutyric acid will be in the anionic form, i.e. the basic form, leading 
to a rise in pH of the SBF. However, once the concentration of 3-hydroxybutyric acid reaches 
beyond a critical concentration due to the degradation of the polymer, the SBF is no longer 
able to maintain the pH at 7.35 and the pH falls slightly due to the acidic nature of  
3-hydroxybutyric acid. 
The cellular morphology and proliferation on biomaterials may be affected by the presence of 
non-structural patterns and surface-protein interactions. Several studies previously analysed 
the proliferation of different cell lines on both P(3HB) and bacterial cellulose membranes, 
confirming their non-toxicity and applicability as scaffolds for cell proliferation. However, 
depending on the cell lines used, the effect of the biomaterial on the proliferation rate and the 
cell morphology may be quite different.90 Several studies showed that the cytotoxicity of a 
biomaterial is many times cell-specific.91 The results of the cell proliferation assay performed 
on the 3D composite materials corresponded with the observations on SEM images of the 
Murine ATDC5 cells grown on both scaffold materials. The cell proliferation results achieved 
with the neat P(3HB) and P(3HB)/MFC composite containing 40 wt% MFC, did not differ 
much on Day 1. This can be attributed to the microstructure, the 3D topography, surface-protein 
interactions and the presence of 3D pores where cells infiltrated, thereby resulting in good cell 
growth. Chondrocytes obtain a more extended morphology when grown on a two-dimensional 
surface, while a three-dimensional structure supports chondrocyte proliferation and 
differentiation.92 Thus; the 3D structure and surface-protein interactions were the dominant 
factors in enhancing cell adhesion and proliferation. When a solid surface is placed in a solution 
containing a given protein, the protein will generally tend to rapidly adsorb until it saturates 
the surface. If the surface is hydrophobic, like in the case of the neat P(3HB) scaffold, the 
protein will tend to adsorb by the various hydrophobic patches of residues present on the 
protein’s amphiphilic surface, with the protein then tending to unfold and spread its 
hydrophobic core over the surface owing to the thermodynamic driving force to reduce the net 
hydrophobic surface area of the system exposed to the solvent. Hydrophilic surface, on the 
other hand, tend to interact with the charged and polar functional groups of the protein’s 
surface, thus influencing adsorbed protein orientation, but with a lower tendency to cause the 
protein to unfold and spread over the surface. Because proteins generally do not tend to adsorb 
non-specifically to themselves, protein adsorption tends to stop once complete monolayer 
coverage is achieved. The final organisation of the adsorbed protein layer (i,e, the organisation, 
conformation, and packing arrangement of the adsorbed proteins) depends on the chemical and 
physical structure of the protein, the surface, and the aqueous solution, and the thermodynamics 
of the interactions between these system components. It is also strongly influenced by the 
kinetics of mass transport of the protein to the surface from solution relative to the kinetics of 
the protein’s movement on the surface, the kinetics of protein spreading on the surface and the 
physical constraints imposed by protein-protein interactions on the surface93. Hence, the 
composite scaffolds can be said to have amphiphilic properties and were expected to have more 
organised, conformed, and packing arrangement of the adsorbed proteins than the neat P(3HB) 
scaffold and this will encourage increased proliferation as observed in this work. Hence, the 
amount and type of serum protein that adhered to the substrates vary on different chemical 
surfaces; this can also affect cell behaviour on the substrates94. 
 
5. Conclusion 
Scaffolds provide a 3D environment that is desirable for the production of cartilaginous tissue. 
Current work on alternatives to single phase 3D scaffolds is expanding, and the potential of 
MFC and P(3HB) composites have been explored in this work. The much improved load 
bearing properties of the composite scaffolds in combination with the biocompatibility 
achieved provided evidence of the future potential of these natural polymer-based 3D 
P(3HB)/MFC composite scaffolds in load bearing joint cartilages. The results obtained 
highlighted the positive effects of the MFC on the effective microtopography within the 
composite. In addition, the three-dimensional composite produced in this work were 
characterised by high porosity, with a regular distribution of pore diameter, high-surface area 
to volume ratio, and morphological similarities to extracellular matrix. These physical 
characteristics promote favourable biological responses of seeded cells in vitro, including 
enhanced cell attachment, proliferation and maintenance of the chondrocytic phenotype.95 
Further studies using these promising materials will involve detailed in vivo work which will 
allow the generation of preclinical data for these promising materials. Hence, in conclusion, 
the results obtained in this work confirm for the first time the huge potential of the 
P(3HB)/MFC composites in the development of load bearing polymer-based cartilage repair 
implants to meet the currently unmet needs in this area.  
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